Future therapies for pemphigus vulgaris: Rituximab and beyond

scientific article

Future therapies for pemphigus vulgaris: Rituximab and beyond is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JAAD.2015.11.008
P698PubMed publication ID26792592

P2093author name stringAmy Huang
Jacob Levitt
Raman K Madan
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectrituximabQ412323
pemphigus vulgarisQ3899001
Pemphigus vulgarisQ10622783
P304page(s)746-753
P577publication date2016-01-11
P1433published inJournal of the American Academy of DermatologyQ15757046
P1476titleFuture therapies for pemphigus vulgaris: Rituximab and beyond
P478volume74

Reverse relations

cites work (P2860)
Q55413268Autoimmune Diseases and Their Manifestations on Oral Cavity: Diagnosis and Clinical Management.
Q49382688British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.
Q64996575Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology.
Q47378354Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in Germany.
Q56603745Pemphigus
Q92312713Pemphigus vulgaris
Q47219879Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.
Q55361376Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions.

Search more.